Corbus Pharmaceuticals (CRBP) Competitors $13.00 -0.33 (-2.48%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CRBP vs. AUTL, OCS, CGEM, PRTA, TRDA, ABUS, TECX, STOK, ALT, and CRGXShould you be buying Corbus Pharmaceuticals stock or one of its competitors? The main competitors of Corbus Pharmaceuticals include Autolus Therapeutics (AUTL), Oculis (OCS), Cullinan Therapeutics (CGEM), Prothena (PRTA), Entrada Therapeutics (TRDA), Arbutus Biopharma (ABUS), Tectonic Therapeutic (TECX), Stoke Therapeutics (STOK), Altimmune (ALT), and CARGO Therapeutics (CRGX). These companies are all part of the "pharmaceutical products" industry. Corbus Pharmaceuticals vs. Autolus Therapeutics Oculis Cullinan Therapeutics Prothena Entrada Therapeutics Arbutus Biopharma Tectonic Therapeutic Stoke Therapeutics Altimmune CARGO Therapeutics Autolus Therapeutics (NASDAQ:AUTL) and Corbus Pharmaceuticals (NASDAQ:CRBP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking. Do analysts prefer AUTL or CRBP? Autolus Therapeutics presently has a consensus price target of $10.40, suggesting a potential upside of 354.15%. Corbus Pharmaceuticals has a consensus price target of $62.00, suggesting a potential upside of 376.92%. Given Corbus Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Corbus Pharmaceuticals is more favorable than Autolus Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autolus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Corbus Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11 Which has more risk & volatility, AUTL or CRBP? Autolus Therapeutics has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500. Comparatively, Corbus Pharmaceuticals has a beta of 2.57, suggesting that its stock price is 157% more volatile than the S&P 500. Do institutionals & insiders hold more shares of AUTL or CRBP? 72.8% of Autolus Therapeutics shares are held by institutional investors. Comparatively, 64.6% of Corbus Pharmaceuticals shares are held by institutional investors. 25.7% of Autolus Therapeutics shares are held by insiders. Comparatively, 4.0% of Corbus Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer AUTL or CRBP? In the previous week, Autolus Therapeutics and Autolus Therapeutics both had 3 articles in the media. Corbus Pharmaceuticals' average media sentiment score of 0.52 beat Autolus Therapeutics' score of -0.21 indicating that Corbus Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autolus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Corbus Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is AUTL or CRBP more profitable? Corbus Pharmaceuticals' return on equity of -42.28% beat Autolus Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Autolus TherapeuticsN/A -63.65% -36.54% Corbus Pharmaceuticals N/A -42.28%-32.92% Does the MarketBeat Community favor AUTL or CRBP? Corbus Pharmaceuticals received 223 more outperform votes than Autolus Therapeutics when rated by MarketBeat users. However, 67.87% of users gave Autolus Therapeutics an outperform vote while only 66.92% of users gave Corbus Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAutolus TherapeuticsOutperform Votes22667.87% Underperform Votes10732.13% Corbus PharmaceuticalsOutperform Votes44966.92% Underperform Votes22233.08% Which has better valuation & earnings, AUTL or CRBP? Corbus Pharmaceuticals has lower revenue, but higher earnings than Autolus Therapeutics. Corbus Pharmaceuticals is trading at a lower price-to-earnings ratio than Autolus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutolus Therapeutics$10.09M60.39-$208.38M-$1.21-1.89Corbus Pharmaceuticals$880K179.92-$44.60M-$4.69-2.77 SummaryCorbus Pharmaceuticals beats Autolus Therapeutics on 11 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBP vs. The Competition Export to ExcelMetricCorbus PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$158.33M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-2.7710.5990.0517.18Price / Sales179.92195.801,117.00116.99Price / CashN/A57.1642.9637.86Price / Book-8.335.094.784.78Net Income-$44.60M$151.83M$120.31M$225.60M7 Day Performance-13.79%-2.13%-1.92%-1.23%1 Month Performance-22.73%-3.10%11.50%3.36%1 Year Performance144.82%11.54%30.59%16.60% Corbus Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBPCorbus Pharmaceuticals3.8067 of 5 stars$13.00-2.5%$62.00+376.9%+147.6%$158.33M$880,000.00-2.7740AUTLAutolus Therapeutics2.5518 of 5 stars$2.63+5.6%$10.40+295.4%-58.4%$699.82M$1.70M-2.06330OCSOculis1.6423 of 5 stars$17.06-0.2%$29.20+71.2%+57.2%$691.00M$980,000.00-8.852CGEMCullinan Therapeutics1.8003 of 5 stars$11.81+0.5%$31.67+168.1%+32.7%$687.67M$18.94M-4.1430News CoveragePRTAProthena1.6218 of 5 stars$12.74-0.4%$61.83+385.3%-58.8%$685.53M$133.35M-5.16173Analyst ForecastNews CoverageTRDAEntrada Therapeutics2.5961 of 5 stars$18.25+3.3%$25.67+40.6%+17.3%$682.92M$129.01M11.11110Gap DownABUSArbutus Biopharma2.551 of 5 stars$3.57+2.6%$5.50+54.1%+45.2%$676.48M$18.14M-8.0973Positive NewsTECXTectonic Therapeutic2.9296 of 5 stars$45.58+0.6%$72.25+58.5%N/A$672.44MN/A-7.70120Positive NewsSTOKStoke Therapeutics4.194 of 5 stars$12.28+1.8%$20.83+69.7%+140.1%$650.47M$8.78M-5.74100Analyst ForecastNews CoverageGap DownALTAltimmune1.9536 of 5 stars$9.07+0.4%$20.00+120.5%+3.4%$645.10M$52,000.00-5.8350News CoveragePositive NewsCRGXCARGO Therapeutics1.4622 of 5 stars$14.01+2.0%$31.80+127.0%-20.0%$644.85MN/A-3.23116 Related Companies and Tools Related Companies AUTL Alternatives OCS Alternatives CGEM Alternatives PRTA Alternatives TRDA Alternatives ABUS Alternatives TECX Alternatives STOK Alternatives ALT Alternatives CRGX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRBP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRBP Stock Alerts